Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.
about
Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@en
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@nl
type
label
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@en
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@nl
prefLabel
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@en
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@nl
P2093
P2860
P356
P1476
Phase I Studies of Acebilustat ...... Patients with Cystic Fibrosis.
@en
P2093
E B Springman
G MacGregor
J S Elborn
R Grosswald
P2860
P356
10.1111/CTS.12428
P407
P50
P577
2016-11-02T00:00:00Z